Why the study?
Despite a good prognosis, many patients with coronary microvascular dysfunction have poor quality of life and strong activity limitations due to angina symptoms.
This review summarizes the clinical presentation, risk factors, pathogenesis, diagnosis, and treatment of coronary microvascular dysfunction, highlighting its impact on quality of life.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to CMD's QoL burden; leaves open standardized management pathways pending prospective trials.
Patients with coronary microvascular dysfunction (CMVD) represent a widespread population and despite the good prognosis, many of them have a poor quality of life with strong limitations in their daily activities because of the angina symptoms. This article summarizes the most frequent clinical presentation pictures like stable and unstable microvascular angina. Main risk factors are discussed, followed by the latest updates on the subject about different pathogenic hypotheses, diagnosis and treatment. Not very well understood microvascular alterations, like slow flow phenomenon and no reflow are discussed and both prognosis and the impact of the disease in the quality of life are analyzed.
No takes yet. Share an insight, caveat, or question.
Sucato et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: